13F Data
13F filer · CIK 2010850

Decheng Capital LLC

MENLO PARK, CA · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$731.7M
+$70.4M vs prior
Positions
14
New / sold out
1 / 1
Added / reduced
0 / 3
Turnover
0.1%
buys $625.2K · sells $15.0M
Top-10 weight
98.1%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewTANGO THERAPEUTICS INC+20,000–+$625.2K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedREVOLUTION MEDICINES INC(NSM)-40,833-43.7%$-7.6M
ReducedNEWAMSTERDAM PHARMA CO NV-148,170-45.6%$-5.0M
Sold outKRYSTAL BIOTECH INC-7,300-100.0%$-1.9M
ReducedArcus Biosciences, Inc-13,040-2.7%$-402.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2023: $357.9MQ1 2024: $745.6MQ2 2024: $326.3MQ3 2024: $422.2MQ4 2024: $466.2MQ1 2025: $356.5MQ2 2025: $396.0MQ3 2025: $573.2MQ4 2025: $743.4MQ1 2026: $661.3MQ2 2026: $731.7M
Q4 2023Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1CG ONCOLOGY INCCOM6,371,669$452.7M61.87%
2Nuvation Bio Inc.COM25,954,439$147.4M20.15%
3AARDVARK THERAPEUTICS INCCOM3,917,299$22.6M3.08%
4Aclaris Therapeutics, Inc.COM4,041,736$21.4M2.92%
5Upstream Bio Inc.COM2,724,868$18.9M2.58%
6Arcus Biosciences, IncCOM464,779$14.3M1.96%
7Equillium Inc.COM4,447,308$14.2M1.94%
8REVOLUTION MEDICINES INC(NSM)COM52,667$9.9M1.35%
9Lyell Immunopharma, Inc.COM692,050$9.7M1.33%
10BeyondSpring Inc.SHS3,800,702$6.7M0.91%
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.